NeuroOne Medical Technologies 8-K Report: Key Updates & Insights

Here's a concise analysis and extraction of key information from the provided financial report section:
Key Information Extracted:
- Entity Information:
- Name: NeuroOne Medical Technologies Corporation
- CIK Number: 0001500198
- SEC File Number: 001-40439
- EIN: 27-0863354
- Address: 7599 Anagram Dr., Eden Prairie, MN 55344
- Phone Number: 952-426-1383
- Filing Type:
- Form: 8-K (current report used to disclose ongoing events that are important to shareholders)
- Filing Date:
- Date of Report: January 8, 2025
- Stock Information:
- Common Stock: Par value of $0.001 per share
- Ticker Symbol: NMTC
- Exchange: NASDAQ
- Context and Measurement:
- Period Start Date: January 8, 2025
- Period End Date: January 8, 2025
- Currency Unit: USD (U.S. Dollars)
- Shares Unit: Shares
Insights:
- The filing indicates that NeuroOne Medical Technologies Corporation is actively reporting significant events or changes that could impact investors, as reflected in the filing of an 8-K.
- The company is listed on NASDAQ under the ticker NMTC, which provides context for its market presence and the trading environment.
- The filing date coincides with the reporting period, suggesting the information provided is recent and relevant for stakeholders.
- The par value of the common stock at $0.001 indicates a low nominal value, which may imply a strategy focused on growth and capital appreciation rather than immediate high valuations.
This information is essential for analysts and investors monitoring NeuroOne Medical Technologies Corporation's activities, financial health, and stock performance.